Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fay-Lynn Asselman

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|September 14, 2024
Feasibility and Reproducibility of Isokinetic Dynamometry in Children with Neuromuscular DiseasesDanny R van der Woude, Tim Takken, Thijs Ruyten, et al.
Journal of Neuromuscular Diseases|April 25, 2022
Motor Unit and Capillary Recruitment During Fatiguing Arm-Cycling Exercise in Spinal Muscular Atrophy Types 3 and 4Laura E Habets, Bart Bartels, Fay-Lynn Asselman, et al.
The Cochrane Database of Systematic Reviews|December 12, 2019
Drug treatment for spinal muscular atrophy type IRenske I Wadman, W Ludo van der Pol, Wendy Mj Bosboom, et al.
BMC Neurology|March 24, 2023
The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trialKim Kant-Smits, Bart Bartels, Fay-Lynn Asselman, et al.
Neuromuscular Disorders : NMD|June 11, 2024
Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3Danny R van der Woude, Renske I Wadman, Fay-Lynn Asselman, et al.
NMR in Biomedicine|January 22, 2021
Quantification of disease progression in spinal muscular atrophy with muscle MRI-a pilot studyLouise A M Otto, Martijn Froeling, Ruben P A van Eijk, et al.
The Cochrane Database of Systematic Reviews|February 2, 2020
Drug treatment for spinal muscular atrophy types II and IIIRenske I Wadman, W Ludo van der Pol, Wendy Mj Bosboom, et al.
Journal of Neuromuscular Diseases|January 28, 2026
Longitudinal cohort study of muscle function and metabolic biomarkers in disease-modifying treatment of spinal muscular atrophyLisa Pomp, Jeroen A L Jeneson, Jeanine J Prompers, et al.
Brain : a Journal of Neurology|November 17, 2021
Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophyLaura E Habets, Bart Bartels, Fay-Lynn Asselman, et al.
European Journal of Neurology|May 2, 2021
Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor neuron diseaseMarieke H J van Rosmalen, H Stephan Goedee, Rosina Derks, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|September 14, 2024
Feasibility and Reproducibility of Isokinetic Dynamometry in Children with Neuromuscular DiseasesDanny R van der Woude, Tim Takken, Thijs Ruyten, et al.
Journal of Neuromuscular Diseases|April 25, 2022
Motor Unit and Capillary Recruitment During Fatiguing Arm-Cycling Exercise in Spinal Muscular Atrophy Types 3 and 4Laura E Habets, Bart Bartels, Fay-Lynn Asselman, et al.
The Cochrane Database of Systematic Reviews|December 12, 2019
Drug treatment for spinal muscular atrophy type IRenske I Wadman, W Ludo van der Pol, Wendy Mj Bosboom, et al.
BMC Neurology|March 24, 2023
The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trialKim Kant-Smits, Bart Bartels, Fay-Lynn Asselman, et al.
Neuromuscular Disorders : NMD|June 11, 2024
Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3Danny R van der Woude, Renske I Wadman, Fay-Lynn Asselman, et al.
NMR in Biomedicine|January 22, 2021
Quantification of disease progression in spinal muscular atrophy with muscle MRI-a pilot studyLouise A M Otto, Martijn Froeling, Ruben P A van Eijk, et al.
The Cochrane Database of Systematic Reviews|February 2, 2020
Drug treatment for spinal muscular atrophy types II and IIIRenske I Wadman, W Ludo van der Pol, Wendy Mj Bosboom, et al.
Journal of Neuromuscular Diseases|January 28, 2026
Longitudinal cohort study of muscle function and metabolic biomarkers in disease-modifying treatment of spinal muscular atrophyLisa Pomp, Jeroen A L Jeneson, Jeanine J Prompers, et al.
Brain : a Journal of Neurology|November 17, 2021
Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophyLaura E Habets, Bart Bartels, Fay-Lynn Asselman, et al.
European Journal of Neurology|May 2, 2021
Quantitative magnetic resonance imaging of the brachial plexus shows specific changes in nerve architecture in chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy and motor neuron diseaseMarieke H J van Rosmalen, H Stephan Goedee, Rosina Derks, et al.
Pageof 5